Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 placebo-controlled trial of lubiprostone for functional constipation
ChiCTR1800015360Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Apr 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cobiprostone in functional constipation (FC) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Number of spontaneous bowel movements at first week of treatment. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on ChiCTR1800015360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015360.